Senior Director, Pharmacovigilance Quality Assurance

Senior Director, Pharmacovigilance Quality Assurance

Waltham, MA

Dyne Therapeutics is focused on delivering functional improvement for people living with genetically driven neuromuscular diseases. We are developing therapeutics that target muscle and the central nervous system (CNS) to address the root cause of disease. The company is advancing clinical programs for Duchenne muscular dystrophy (DMD) and myotonic dystrophy type 1 (DM1) as well as a preclinical programs for facioscapulohumeral muscular dystrophy (FSHD) and Pompe disease.

At Dyne, we are on a mission to deliver functional improvement for individuals, families and communities. Learn more at  , and follow us on X , Linked In and Facebook .

The Senior Director, Pharmacovigilance Quality Assurance (PVQA) leads the strategy, governance, and execution of Dyne’s global pharmacovigilance quality framework. This role sets the direction for PV quality systems and ensures scalable, inspection-ready operations that support high-quality regulatory submissions and continuous patient safety assurance across the portfolio.

This leader designs and evolves Dyne’s Pharmacovigilance Quality Management System, integrating global standards with business needs across clinical and future commercial programs. They serve as a senior advisor on PV quality risks, regulatory expectations, vendor oversight, and inspection readiness while fostering a culture of quality, accountability, and continuous improvement.

This role is based in Waltham, MA.

• Define and own the global PVQA strategy, aligned to Dyne’s development and commercialization roadmap.
• Serve as Dyne’s subject matter expert on PV quality, advising senior leaders on regulatory expectations, compliance risks, inspection trends, and emerging best practices.
• Build, lead, and develop a high-performing PVQA organization, including capability building, mentorship, succession planning, and talent development.
• Represent PVQA in regulatory authority interactions, external audits, health authority inspections, and executive-level quality discussions.
• Partner cross-functionally to embed a culture of quality, accountability, and continuous improvement across PV and related functions.

• Own the end-to-end PV Quality Management System, ensuring scalability, compliance, and operational efficiency across preclinical, clinical, and future commercial stages.
• Establish and monitor enterprise PV quality metrics and KPIs, translating trends into actionable improvements and executive-level reporting.
• Oversee deviations, quality issues, CAPAs, effectiveness checks, and quality events, ensuring timely resolution, robust root cause analysis, and systemic improvement.
• Establish a risk-based PV quality framework to proactively identify, assess, elevate, and mitigate risks across programs, vendors, systems, and regulatory submissions.

• Lead global PV audit and inspection strategy, including internal audits, vendor audits, health authority inspections, and continuous inspection readiness.
• Serve as the senior inspection lead, ensuring consistent messaging, rapid issue resolution, compliant responses, and effective CAPA execution.
• Oversee Pharmacovigilance System Master File governance and ensure alignment with applicable regulatory expectations.
• Provide quality oversight for PV vendors and partners through defined governance, KPIs, audits, performance reviews, and issue escalation pathways.

• Partner with Clinical Development, Regulatory, Quality, IT, Translational, and Commercial readiness teams to ensure end-to-end PV compliance and inspection readiness.
• Influence system strategy for safety databases, validation, data integrity, and compliance, including applicable computerized system requirements such as 21 CFR Part 11.
• Enable efficient, high-quality regulatory submissions by supporting IND through BLA/NDA activities and future commercial launch readiness.
• Develop and scale GVP training, communication, and capability-building programs…